Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up UPDATE

Tue, 10th Sep 2013 08:17

African Barrick Gold: Investec shifts target price from 135p to 137p, while downgrading from hold to sell.Aquarius Platinum: JP Morgan moves target price from 39p to 49p, while downgrading from neutral to underweight. Citi lowers target price from 66p to 54p and downgrades from buy to neutral.AstraZeneca: Jefferies reduces target price from 3400p to 3200p, while keeping its hold recommendation.Barclays: Alphavalue shifts target price from 342.10p to 341.70p downgrading from buy to add.Betfair: Deutsche Bank raises target price from 884p to 945p staying with its hold recommendation. Citi takes target price from 975p to 1150p and reiterates a buy recommendation.BG Group: Morgan Stanley cuts target price from 1400p to 1370p and retains an overweight rating.Billington Holdings: WH Ireland raises target price from 70p to 125p and maintains a buy recommendation.British Sky Broadcasting: Goldman Sachs ups target price from 1010p to 1170p and reiterates a strong buy recommendation.Centamin: Investec moves target price from 45.60p to 50p keeping its buy recommendation.Craneware: Investec places both its target price (prev.: 365p) and its buy recommendation under review. N+1 Singer downgrades to hold with a target price of 375p.Daily Mail & General Trust: Goldman Sachs raises target price from 695p to 780p, but still recommends selling.Darty: Alphavalue shifts target price from 73.20p to 73.80p and upgrades from sell to reduce.Eland Oil & Gas: Canaccord Genuity lowers target price from 180p to 173p, while leaving its buy recommendation unchanged.Evraz: JP Morgan reduces target price from 252p to 116p keeping its underweight rating.Fenner: Investec ups target price from 330p to 370p and stays with its hold recommendation.GlaxoSmithKline: Jefferies cuts target price from 1825p to 1800p maintaining a hold recommendation.Hilton Food Group: Investec placet both its target price (prev.: 352p) and its add rating under review. Panmure Gordon ups target price from 450p to 480p and keeps a buy recommendation.IGas Energy: Canaccord Genuity moves target price from 174p to 181p retaining a buy recommendation.Intertek Group: Deutsche Bank increases target price from 2820p to 3243p reiterating a hold recommendation.ISG: WH Ireland moves target price from 240p to 250p and reiterates its buy recommendation.Ithaca Energy: Liberum Capital initiates with a target price of 210p and a buy recommendation.Lonmin: JP Morgan takes target price from 330p to 400p and maintains an overweight rating. Citi ups target price from 374p to 418p keeping a buy recommendation.Moneysupermarket: Westhouse Securities downgrades to add with a target price of 195p.Oxford Instruments: Investec ups target price from 1320p to 1500p, while its hold recommendation remains unaltered.Randgold Resources: Investec increases target price from 4981p to 5018p leaving its hold recommendation unchanged.Regus: Panmure Gordon takes target price from 200p to 250p and stays with its buy recommendation.Rio Tinto: JP Morgan raises target price from 4200p to 4300p reiterating an overweight rating.SABMiller: HSBC increases target price from 3400p to 3600p upgrading to overweight.SSE: Morgan Stanley ups target price from 1185p to 1280p, while leaving its underweight rating unchanged.Surgical Innovations: Panmure Gordon shifts target price from 6.60p to 7.60p, while its buy recommendation remains unaltered.Unilever: Deutsche Bank raises target price from 2590p to 2800p upgrading to buy.WPP Group: Goldman Sachs increases target price from 1340p to 1600p and keeps a buy recommendation. Berenberg ups target price from 1050p to 1085p, but still recommends selling.
More News
2 Aug 2023 14:28

GSK sues Pfizer in US for patent infringement over RSV vaccine

Aug 2 (Reuters) - British biopharmaceutical giant GSK sued Pfizer in Delaware federal court on Wednesday, accusing Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo of violating GSK's patent rights in its rival RSV shot Arexvy.

Read more
2 Aug 2023 10:41

Sensodyne maker Haleon's shiny forecast signals price hikes unlikely to dent demand

Shares down 1% on slight decline in H1 adj operating margin

*

Read more
2 Aug 2023 08:23

TOP NEWS: Haleon boosts annual guidance after solid first half

(Alliance News) - Haleon PLC on Wednesday upped its annual organic revenue growth guidance following a solid revenue performance in the first half of 2023.

Read more
31 Jul 2023 19:42

IN BRIEF: GSK hails US FDA approval for cancer treatment, Jemperli

GSK PLC - London-based pharmaceutical company - Jemperli plus chemotherapy approved in the US by the Food & Drug Administration as the first new frontline treatment option in decades for primary advanced or recurrent endometrial cancer. Notes Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy. Hesham Abdullah, senior vice president and global head of oncology development at GSK, says: "Today's approval underscore our belief in the potential for Jemperli to transform cancer treatment as a backbone immuno-oncology therapy."

Read more
31 Jul 2023 12:21

DIRECTOR DEALINGS: Qinetiq, Tesco and GSK executives sell shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced late last week and not separately reported by Alliance News:

Read more
31 Jul 2023 09:16

LONDON BROKER RATINGS: Oddo BHF raises IAG to 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
26 Jul 2023 11:06

GSK raises 2023 outlook boosted by vaccine, HIV drug sales

Q2 sales and earnings beat estimates

*

Read more
26 Jul 2023 09:28

TOP NEWS: GSK raises annual guidance on quarterly earnings growth

(Alliance News) - GSK PLC on Wednesday upgraded its full-year guidance, after seeing a strong quarterly performance on the strength of segments like HIV and Vaccines.

Read more
26 Jul 2023 07:55

GSK lifts full-year guidance after 'excellent' Q2

(Sharecast News) - GSK lifted its full-year guidance on Wednesday after an "excellent" second quarter.

Read more
24 Jul 2023 08:25

GSK says HIV prevention drug recommended for marketing in Europe

(Alliance News) - GSK PLC on Monday said ViiV Healthcare's cabotegravir for HIV prevention has received a positive opinion by the European Medicines Agency for marketing authorisation.

Read more
24 Jul 2023 07:07

GSK's ViiV gets Europe nod for HIV prophylaxis

(Sharecast News) - Pharmaceuticals giant GSK announced on Monday that its majority-owned HIV specialist subsidiary ViiV Healthcare has received a positive opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP), recommending marketing authorisation for 'cabotegravir' long-acting (LA) injectable and tablets for HIV prevention.

Read more
22 Jul 2023 18:32

Bavarian Nordic ends RSV vaccine programme after poor trial results

July 22 (Reuters) - Denmark-based Bavarian Nordic said on Saturday it was ending its respiratory syncytial virus (RSV) vaccine programme as its Phase 3 clinical trial did not meet all the primary goals of preventing lower respiratory tract disease.

Read more
14 Jul 2023 09:13

LONDON BROKER RATINGS: HSBC says 'buy' AstraZeneca but 'reduce' GSK

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
14 Jul 2023 07:56

LONDON BRIEFING: Burberry shines in China; ITV-All3Media deal unlikely

(Alliance News) - Stocks in London are expected to slip into the red at Friday's open, in a tepid conclusion to what has been a largely positive week for global equities, as the market prices in a lower peak for US interest rates.

Read more
13 Jul 2023 16:13

Sensodyne toothpaste-maker Haleon planning job cuts - The Guardian

July 13 (Reuters) - Haleon, the world's biggest standalone consumer health business, is planning to cut hundreds of roles in the UK and worldwide, the Guardian reported on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.